Wellspring Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.34M Sell
3,616
-423
-10% -$432K 0.29% 37
2026
Q1
$3.72M Buy
4,039
+1,706
+73% +$1.73M 0.28% 41
2025
Q4
$2.51M Buy
2,333
+1,731
+288% +$1.66M 0.2% 48
2025
Q3
$459K Buy
602
+16
+3% +$11.9K 0.04% 90
2025
Q2
$457K Buy
586
+40
+7% +$31.1K 0.05% 88
2025
Q1
$451K Buy
546
+15
+3% +$12.5K 0.05% 77
2024
Q4
$410K Sell
531
-246
-32% -$204K 0.04% 85
2024
Q3
$689K Buy
777
+141
+22% +$127K 0.08% 68
2024
Q2
$576K Buy
636
+244
+62% +$195K 0.08% 76
2024
Q1
$305K Buy
+392
New +$279K 0.05% 96
2023
Q1
Sell
-577
Closed -$211K 128
2022
Q4
$211K Buy
+577
New +$205K 0.07% 101

Other funds holding LLY

Wellspring Financial Advisors's LLY Position: Q2 2026 in Review

Wellspring Financial Advisors reduced its Eli Lilly (LLY) stake by 10% in Q2 2026, selling an estimated $432K and leaving 3,616 shares worth $4.34M. The position accounts for 0.29% of the portfolio, ranked #37.

Wellspring Financial Advisors first reported a position in LLY in Q4 2022 and has held it in 11 quarters since. 1,565 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Wellspring Financial Advisors held 3,616 shares of Eli Lilly worth $4.34M as of Q2 2026.
  • Wellspring Financial Advisors sold 423 Eli Lilly shares in Q2 2026, an estimated $432K.
  • Eli Lilly made up 0.29% of Wellspring Financial Advisors's portfolio in Q2 2026, its #37 holding.
  • Wellspring Financial Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 11 quarters since.
  • 1,565 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wellspring Financial Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.